Novartis AG (NVS)

NYSE - Nasdaq Real Time Price. Currency in USD

109.35

+0.95

(+0.88%)

At close: 04:00PM EDT

108.92

-0.43

(-0.39%)

After hours:

07:58PM EDT

Loading interactive chart...

Reuters
Novartis CEO 'very confident' on sales target, doesn't fear patent cliff - newspaper
Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday, with the pharmaceuticals giant having nothing to fear from the end of patent protection on some drugs. "I am very confident that we will achieve average growth of at least 5% per year until 2028," Narasimhan told Swiss newspaper Finanz und Wirtschaft. Narasimhan said he was confident the company would reach its growth target despite the imminent expiry of patents on some medications including Entresto used to treat heart failure.
Zacks
Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
LLY, MRK, PFE, ABBV and NVS announce report third-quarter results.